logo
    Sign Up
    • logo
    • Sign UpSearch

    Stay Ahead with the Latest Oncology Insights

    Breaking news and expert analysis for today’s oncology professionals.

    TREATMENT ALGORITHMS
    Browse all TREATMENT ALGORITHMS
    Recent and Upcoming Advancements in Treatment Options for SCLC

    TREATMENT ALGORITHMS

    Recent and Upcoming Advancements in Treatment Options for SCLC

    Ticiana Leal

    Selecting Up-Front Treatments for NSCLC with Targetable Mutations

    TREATMENT ALGORITHMS

    Selecting Up-Front Treatments for NSCLC with Targetable Mutations

    Susan Scott

    Navigating Metastatic NSCLC Without Targetable Mutations: Frontline St...

    TREATMENT ALGORITHMS

    Navigating Metastatic NSCLC Without Targetable Mutations: Frontline St...

    Mark Awad

    JOURNAL CLUB
    Browse all JOURNAL CLUB
    FDA Approval of Cabozantinib - CABINET in pNET & epNET

    JOURNAL CLUB

    FDA Approval of Cabozantinib - CABINET in pNET & epNET

    Dr. Aman Chauhan

    Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive...

    JOURNAL CLUB

    Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive...

    Thomas Powles

    TOX CHECK
    Browse all TOX CHECK
    How to Manage Anti-EGFR Toxicities in NSCLC

    TOX CHECK

    How to Manage Anti-EGFR Toxicities in NSCLC

    Gilberto Lopes

    Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

    TOX CHECK

    Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

    Midhun Malla, Rachna Shroff

    Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

    TOX CHECK

    Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

    Tanmayi Pai, Enrique Grande, Pashtoon Kasi

    CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects...

    TOX CHECK

    CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects...